Searched for
AUROBINDO PHARMA TARGET PRICE
JM Financial sees up to 28% upside in Dr Reddy’s and Aurobindo Pharma. Should you buy?JM Financial retained Buy ratings on Dr Reddy’s Laboratories and Aurobindo Pharma, seeing up to 28% upside over the next 12 months. The bro...- Quant Mid Cap Fund exits ICICI Bank, 2 others and adds 5 stocks in AugustQuant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...
- Paytm shares jump 7% as Jefferies, other brokerages raise target prices and earnings estimates after new UPI chargesPaytm shares surged over 7% after brokerages raised target prices following the introduction of MDR on select UPI transactions above Rs 2,0...
- Stocks in news: Yes Bank, Vedanta, Groww, BHEL, Bharat Forge and NBCCIndian equity markets closed lower on Tuesday, extending their monthly decline. Nifty50 reached a key support level, indicating a potential...
- HSBC raises ACME Solar target price by 15%; stock jumps 5%. Why is the brokerage bullish?ACME Solar shares rose sharply after HSBC raised its target price by 15% to Rs 450 and retained its Buy rating. The brokerage sees signs of...
- Tech picks: Adani Ports, Data Patterns among 5 stocks that could give up to 23% returns in short termTechnical analysts recommend five stocks, including Black Box, Adani Ports, ABSL AMC, Torrent Pharma and Data Patterns, with upside potenti...
- Coforge shares fall over 3%. What are Jefferies, Emkay saying after Chairman, independent director exit?Coforge shares fell after independent director and NRC chairperson DK Singh resigned, days after chairman OP Bhatt stepped down, raising co...
- HDFC Bank share price target: What are Jefferies, 3 other foreign brokerages saying as CEO hunt intensifies?HDFC Bank shares on Tuesday as the lender submitted two CEO candidates to the RBI, intensifying focus on its leadership transition. Jefferi...
- BSE, Groww, other broking stocks in focus as SEBI proposes changes to CAS. What does it mean for investors?BSE, Groww, Angel One and Motilal Oswal are in focus after Sebi proposed changes to the Closing Auction Session and expiry-day settlement m...
- Stocks in news: Tata Group stocks, HDFC Bank, Coforge, HFCL, Sun Pharma and Varun BeveragesOn September 11, Indian stock markets experienced a remarkable bounce back after an initial dip at opening. Key index heavyweights attracte...
- Jefferies says Sebi's proposed CAS changes will remove uncertainty, but still remains negative on BSE. Here’s whyJefferies expects Sebi’s proposed CAS changes to reduce expiry-day volatility and uncertainty but remains negative on BSE shares, citing li...
- Vodafone Idea shares zoom 102% in one year. Is there more steam left after multibagger returns?Vodafone Idea shares have surged 102% over the past year, prompting investors to reassess whether the rally has further room to run. While ...
- Nifty may rebound to 23,800; Rupak De picks Apollo, Laurus Labs and Eternal for the weekThree stocks have emerged as top technical picks for the week, with Apollo, Laurus Labs and Eternal showing positive chart setups. Apollo i...
- Jefferies cuts KEI Industries target price by 11%. Will UltraTech’s entry put the company at risk?Jefferies has cut its target price for KEI Industries by 11% to Rs 6,150, citing concerns over UltraTech Cement’s entry into wires and cabl...
- Midcap rally hides a deeper split: Every second stock down but index up 11% in 1 year. Are investors walking on thin ice?The Nifty Midcap 150 has gained around 11% over the past year, outperforming the Nifty’s 6% decline. However, the gains have been uneven, w...
- BSE shares fall 3% as rival NSE gets closer to mega IPO. More pain ahead?BSE shares fell on Friday after rival NSE announced its Rs 22,662-crore IPO, with the issue set to open on September 17. Bernstein has an ‘...
- Explained: Why Bernstein prefers MCX over BSE as volumes plummet amid CAS chaosBernstein has favoured MCX over BSE as commodity derivatives volumes maintain strong momentum while equity derivatives activity weakens ami...
- India’s textile boom ahead? Why Jefferies is bullish on Welspun, RaymondJefferies upgraded Welspun Living to Buy and more than doubled its target to Rs 260, while initiating coverage on Raymond Lifestyle with a ...
- Aurobindo Pharma launches generic Advair Diskus for asthma and COPD in USLannett Company, part of Aurobindo Pharma, has launched generic Advair Diskus in the US, making it the first complex inhalation product fro...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
Load More
